Your browser doesn't support javascript.
loading
Replacement Therapy in Patients with Von Willebrand Disease-Indications and Monitoring.
Nowak-Göttl, Ulrike; Miesbach, Wolfgang; Koscielny, Jürgen; Dempfle, Carl-Erik; Maegele, Marc; Prondzinski, Mario von Depka; Westrup, Dagmar; Spannagl, Michael.
Afiliação
  • Nowak-Göttl U; Department of Clinical Chemistry, Thrombosis and Hemostasis Unit, University Hospital of Kiel and Lübeck, Kiel, Germany.
  • Miesbach W; Medical Clinic II, Institute of Transfusion Medicine, Goethe University, Frankfurt, Germany.
  • Koscielny J; Institute of Transfusion Medicine, Charité - University Medicine, Berlin, Germany.
  • Dempfle CE; Coagulation Center Mannheim, Mannheim, Germany.
  • Maegele M; Department of Trauma and Orthopedic Surgery, Cologne-Merheim Medical Center, University of Witten/Herdecke, Cologne, Germany.
  • Prondzinski MVD; Werlhof-Institute Hannover, Hannover, Germany.
  • Westrup D; Arnold-Heller-Str. 3, buiding 17, 24105 Kiel, Bad Camberg, Germany.
  • Spannagl M; Department of Hemostasis and Transfusion Medicine, Ludwig-Maximilians University, Munich, Germany.
Hamostaseologie ; 39(4): 326-338, 2019 Nov.
Article em En | MEDLINE | ID: mdl-31364093
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator VIII / Fator de von Willebrand / Terapia de Reposição Hormonal Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Hamostaseologie Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator VIII / Fator de von Willebrand / Terapia de Reposição Hormonal Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Hamostaseologie Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha